Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment
Takuro Mizukami(NTT Medical Center), Takako Eguchi Nakajima(St. Marianna University School of Medicine), Mami Hirakawa(Fujita Health University), Yoshie Nagashima(St. Marianna University School of Medicine), Yu Sunakawa(St. Marianna University School of Medicine), Koki Hamaji(St. Marianna University School of Medicine), Naoki Izawa(St. Marianna University School of Medicine), Michi Shibata(St. Marianna University School of Medicine), Risa Onuki(St. Marianna University School of Medicine), Shinya Mikami(St. Marianna University School of Medicine), Ayako Doi(St. Marianna University School of Medicine), Ayako Yokomizo(Kyoto University), Tsuneaki Tanaka(St. Marianna University School of Medicine), Hiroyuki Arai(St. Marianna University School of Medicine), Takashi Ogura(Kanagawa Cardiovascular and Respiratory Center), Takashi Tsuda(Icahn School of Medicine at Mount Sinai), Yoshiki Horie(St. Marianna University School of Medicine), K. Umemoto(St. Marianna University School of Medicine), Hiroyuki Takeda(St. Marianna University School of Medicine)
Cited by 12
Related Papers
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
|New England Journal of Medicine|2010|5.6k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
|Nature Medicine|2020|366
Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
|Frontiers in Oncology|2019|199